Literature DB >> 12972013

Prostaglandins for induction of second-trimester termination and intrauterine death.

Suk Wai Ngai1, Oi Shan Tang, Pak Chung Ho.   

Abstract

The introduction of synthetic prostaglandin has revolutionized the treatment protocol for induction of second-trimester abortion and intrauterine death. Gemeprost is the only licensed synthetic prostaglandin analogue for second-trimester abortion in the United Kingdom. However, it is expensive and needs to be stored in a refrigerator. Misoprostol is marketed for use in the prevention and treatment of peptic ulcer. It is inexpensive and can be stored at room temperature. It has been widely used for induction of second-trimester abortion and intrauterine death. Misoprostol, 400 microg given vaginally every 3hours, is probably the optimal regimen for second-trimester abortion. The combination of misoprostol and mifepristone significantly reduced the induction-to-abortion interval when compared with the misoprostol-only regimen. In addition, misoprostol can also be used as a cervical priming agent prior to dilatation and evacuation in second-trimester abortion.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12972013     DOI: 10.1016/s1521-6934(03)00068-3

Source DB:  PubMed          Journal:  Best Pract Res Clin Obstet Gynaecol        ISSN: 1521-6934            Impact factor:   5.237


  3 in total

1.  Uterine rupture after prostaglandin analogues to induce midtrimester abortion.

Authors:  Elisa Maria Pappalardo; Michele La Greca; Giusi Rapisarda; Daniele Consoli
Journal:  J Prenat Med       Date:  2010-01

2.  Use of intravenous sulprostone for the termination of pregnancy with fetal death in second and early third trimester of pregnancy.

Authors:  Anita K Mohan; Mariam Mathew; Syed G Rizvi
Journal:  Sultan Qaboos Univ Med J       Date:  2008-11

3.  A Pill in the Lifeworld of Women in Burkina Faso: Can Misoprostol Reframe the Meaning of Abortion.

Authors:  Seydou Drabo
Journal:  Int J Environ Res Public Health       Date:  2019-11-12       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.